openPR Logo
Press release

APAC Witnesses Surge in Adoption of Advanced HIV Rapid Test Kits, Paving the Way for Timely Detection and Treatment, the Market to Worth $487.70 Billion in 2028 - Arizton

According to Arizton's research report, the APAC HIV rapid test kits market is growing at a CAGR of 2.57% during the forecast period.

To Know More, Download the Free Sample Report: https://www.focusreports.store/request-sample/asia-pacific-hiv-rapid-test-kits-insights

The APAC market is witnessing significant growth due to the increasing prevalence of HIV infection and the increase in government support and funding for HIV management. The APAC HIV rapid test kits market growth can be attributed to the rise in the target patient population, high acceptance of HIV rapid test kits among people, high awareness of HIV infection, and increase in government support and funds.

Key Highlights

The offline segment dominates the distribution channels and accounts for 68.77% of the APAC HIV rapid test kits market share. Easy access and availability with the convenience of buyers are the major factors that drive significant sales through offline channels. 

The rise of 4th-generation and 5th-generation rapid test kits in the market has become more popular in the coming years. One of the leading market players OraSure Technologies, got approval for a home test kit known as the OraQuick In-Home HIV Test (4th generation), which gives results in 20 to 40 minutes.  

Abott, OraSure Technologies, Bio-Rad Laboratories, ChemBio Diagnostics, and Biomerieux are the leading players in the APAC HIV rapid test kits market. The market offers tremendous growth opportunities for existing and future/emerging players because of the high prevalence of HIV and awareness about the HIV status of the population. 

Why this Report?

This report offers market size & forecast data for the HIV rapid test kits market in the APAC region. The revenue generated from the sale of HIV rapid test kits, which are a type of self-test kit, and HIV rapid test kits purchased by individuals who can perform HIV rapid tests at home alone, are included in the report. Mail-in HIV self-test kits and Laboratory-based antigen/antibody HIV tests are excluded from the report's scope. This report provides a comprehensive and current market scenario of the APAC HIV rapid test kits, including the APAC HIV rapid test kits market size, anticipated market forecast, relevant market segmentations, and industry trends. 

Buy this Research @ https://www.focusreports.store/report/asia-pacific-hiv-rapid-test-kits-insights

How Will the APAC HIV Rapid Test Kits Market Insights Help Business Growth?

Development and designing of in-licensing and out-licensing strategies to identify companies with the most robust services

Analysis of several micro-market indicators considering growth factors, market prospects, and contribution to the market strategically

The Following Market Segment Analysis is Included in this Report

Technology type

Lateral Flow Immunoassay

Immuo-filtration

Sample type

Blood

Oral Fluid

Others

Distribution Channel type

Offline

Online

Key Vendors

Abbott Laboratory

Bio-Rad Laboratory

BioMerieux

ChemBio Diagnostics

OraSure Technologies

Other Prominent Vendors

bioLytical Laboratories

Biosynex

DIALAB

AccuBioTech

Cupid Limited

Nanjing Synthgene Medical Technology

HUMAN Diagnostics World

INTEC

J. Mitra & Co.

Meril Life Sciences

MP Biomedicals

Medsource Ozone Biomedicals

Premier Medical

SD Biosensor

Türklab A.S.

Trinity Biotech

Atomo Diagnostics

KHB (SHANGHAI KEHUA BIO-ENGINEERING)

Wantai BioPharma

Wondfo

Key Questions Answered in the Report:

What was the size of the APAC HIV rapid test kits market in 2022?

Which country holds the highest market share in HIV rapid test kit in APAC?

Which is the growth rate of HIV rapid test kit market in APAC?

Table of Contents

CHAPTER - 1: HIV Rapid Test Kits Market Overview

Executive Summary

Introduction

Key Findings

CHAPTER - 2: HIV Rapid Test Kits Market

APAC: Projected Revenue of HIV Rapid Test Kits Market (2022-2028; $Millions)

CHAPTER - 3: HIV Rapid Test Kits Market Segmentation Data

APAC: Projected Revenue by Technology type (2022-2028; $Million)

Technology type Snapshot

Lateral Flow Immunoassay type

Immuno-filtration type

Market Share by Technology Type Snapshot

APAC: Projected Revenue by Sample type (2022-2028; $Millions)

Sample type Snapshot

Blood

Oral Fluid

Urine

Market Share by Sample Type Snapshot

APAC: Projected Revenue of HIV Rapid Test Kits by Distribution channel type (2022-2028; $Millions)

Distribution Channel type Snapshot

Offline

Online

Market Share by Distribution Channel Type Snapshot

China: Projected Revenue of HIV Rapid Test Kits Market (2022-2028; $Millions)

India: Projected Revenue of HIV Rapid Test Kits Market (2022-2028; $Millions)

Indonesia: Projected Revenue of HIV Rapid Test Kits Market (2022-2028; $Millions)

Thailand: Projected Revenue of HIV Rapid Test Kits Market (2022-2028; $Millions)

Vietnam: Projected Revenue of HIV Rapid Test Kits Market (2022-2028; $Millions)

CHAPTER - 4: HIV Rapid Test Kits Prospects & Opportunities

HIV Rapid Test Kits Market Drivers

HIV Rapid Test Kits Market Trends

HIV Rapid Test Kits Market Constraints

CHAPTER - 5: HIV Rapid Test Kits Industry Overview

HIV Rapid Test Kits - Competitive Landscape

HIV Rapid Test Kits - Key Players

HIV Rapid Test Kits - Key Company Profiles

HIV Rapid Test Kits - Key Strategic Recommendations

About Focused Reports by Arizton   
Welcome to Focused Reports, an esteemed Arizton Advisory & Intelligence subsidiary committed to delivering precise and insightful market research reports across all key geographies. Our unique selling proposition lies in our affordable pricing, accurate data, in-depth research, and presentation-ready reports. With us, expensive market research is a thing of the past. We aim to be strategic, providing valuable data. Focus Reports is where folks come to name their ideas, create a compelling brand and a great-looking website, and attract customers with digital and social marketing.    

Contact Us:   
Call: +1-312-235-2040                                              
          +1 302 469 0707                                             
Mail: enquiry@arizton.com  
Website: https://www.focusreports.store/   

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release APAC Witnesses Surge in Adoption of Advanced HIV Rapid Test Kits, Paving the Way for Timely Detection and Treatment, the Market to Worth $487.70 Billion in 2028 - Arizton here

News-ID: 3347847 • Views:

More Releases for HIV

HIV Drugs Market - Defeating HIV Together: Advancing Treatment Options for a Bri …
Newark, New Castle, USA: The "HIV Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors HIV Drugs Market: https://www.growthplusreports.com/report/hiv-drugs-market/7792 This latest report researches the industry structure, sales, revenue,
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Introduction to Human Immunodeficiency Virus (HIV) Vaccines 1.1 Overview 1.2 Antiquity of HIV Vaccine Need for the Development of HIV Vaccine Primer of HIV inside the Body 3.1 Inclusion of HIV Virus into the System 3.2 Interaction of HIV with Host 3.3 Eradication of HIV Virus HIV Vaccine Development Process 4.1 Introduction
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways